6. Parkinson disease Clinical trials / Disease details
Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04821830 (ClinicalTrials.gov) | February 12, 2020 | 10/3/2021 | Vigor and the LDR in Parkinson Disease | Vigor and the LDR in Parkinson Disease | Parkinson Disease | Drug: carbidopa/levodopa, as prescribed by treating physician | University of Michigan | National Institute of Neurological Disorders and Stroke (NINDS) | Recruiting | 45 Years | 90 Years | All | 40 | United States |